Detalhe da pesquisa
1.
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.
N Engl J Med
; 389(14): 1273-1285, 2023 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37632466
2.
Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis.
Circulation
; 149(9): 669-683, 2024 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152968
3.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N Engl J Med
; 387(21): 1923-1934, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342113
4.
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project.
Eur Heart J
; 45(12): 1043-1054, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240386
5.
Associations of carotid intima media thickness with gene expression in whole blood and genetically predicted gene expression across 48 tissues.
Hum Mol Genet
; 31(7): 1171-1182, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788810
6.
Association of plasma proteomics with incident coronary heart disease in individuals with and without type 2 diabetes: results from the population-based KORA study.
Cardiovasc Diabetol
; 23(1): 53, 2024 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310303
7.
Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials.
Diabetes Obes Metab
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757725
8.
Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction.
Eur Heart J
; 44(18): 1594-1607, 2023 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988179
9.
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
Eur Heart J
; 44(2): 129-138, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331326
10.
Prognostic Value of Cardiovascular Biomarkers in the Population.
JAMA
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739396
11.
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia.
N Engl J Med
; 382(16): 1520-1530, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197277
12.
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
N Engl J Med
; 382(16): 1507-1519, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187462
13.
Proteomic profiling of longitudinal changes in kidney function among middle-aged and older men and women: the KORA S4/F4/FF4 study.
BMC Med
; 21(1): 245, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407978
14.
Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach.
J Transl Med
; 21(1): 742, 2023 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864227
15.
Risk prediction of atrial fibrillation and its complications in the community using hs troponin I.
Eur J Clin Invest
; 53(5): e13950, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602448
16.
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS).
Curr Atheroscler Rep
; 25(12): 939-946, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015336
17.
Association between the fatty liver index and chronic kidney disease: the population-based KORA study.
Nephrol Dial Transplant
; 38(5): 1240-1248, 2023 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150717
18.
Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods.
Europace
; 25(3): 812-819, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36610061
19.
Pooled analysis of epigenome-wide association studies of food consumption in KORA, TwinsUK and LLS.
Eur J Nutr
; 62(3): 1357-1375, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571600
20.
Medical care and biomarker-based assessment of mortality in two cohorts of patients with chronic coronary syndrome 10 years apart.
BMC Cardiovasc Disord
; 23(1): 428, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644408